The effect of purgative manna and clofibrate on neonatal unconjugated hyperbilirubinemia

This study was conducted to determine the effect of purgative Manna and clofibrate on unconjugated hyperbilirubinemia of term neonates. In this randomized clinical trial study, sixty neonates suffering from unconjugated hyperbilirubinemia were evaluated. The neonates were divided into three groups using balanced block randomization. Group A (control group-received only phototherapy), group B (intervention group-received purgative Manna and phototherapy) and group C (intervention group-received clofibrate and phototherapy). After the intervention, the amount of serum bilirubin reduction was compared between groups. There was no significant difference among group A, B, and C in terms of serum bilirubin reduction in 24, 48 and 72 hours after starting the intervention (P>0.05). The hospital stays in the control group was significantly longer than the intervention groups (P<0.05). No side effects were observed related to using purgative Mienna and clofibrate. The present study showed that prescribing of purgative Manna and clofibrate has no effect on reduction of serum bilirubin level in term neonates with unconjugated hyperbilirubinemia. Thus, it seems that the administration of these drugs is not necessary. Further studies in this regard are recommende

Re: Serum Zinc Concentrations in Children with Acute Bloody and Watery Diarrhoea

Sir, I have two comments regarding the interesting study by Mahyar et al. published in the SQUMJ November 2015 issue.1 Firstly, apart from the two limitations addressed by the authors—failure to estimate serum zinc concentrations after patients had completed their course of treatment and the small sample size—I believe that there is another important limitation to this study. Giardiasis is highly prevalent in developing countries.2 It is commonly linked to chronic diarrhoea and malabsorption; available data indicate that giardiasis is the aetiological agent in 7.0% of childhood cases of acute diarrhoea.3 In Iran, paediatric giardiasis still represents a substantial health threat, with an estimated prevalence of 10.6%.4 Moreover, giardiasis has been shown to be markedly associated with hypozincaemia in the Iranian population.5 In Mahyar et al.’s study, stool cultures were used to determine the causative pathogens in their studied population.1 No growth was seen in 32 (53.3%) patients while 28 (46.7%) patients were found to have bacterial diarrhoea caused by pathogenic Escherichia coli (n = 15), Shigella (n = 10) and Salmonella (n = 3).1 General stool examinations were not carried out prior to the cultures; this could have resulted in the exclusion of a significant number of patients with giardiasis-associated acute diarrhoea.1 Accordingly, this might affect the accuracy of Mahyar et al.’s results. Secondly, Mahyar et al. studied the correlation between serum zinc levels and various inflammatory and non-inflammatory variables.1 The study showed a non-significant correlation between these variables and serum zinc levels; thus, these variables could not be considered predictors of zinc deficiency in Iranian children with acute diarrhoea.1 This is an interesting observation as it contrasts with previously reported observations; Strand et al. studied the association between plasma zinc concentration and several clinical and biochemical variables in a cohort of Nepalese children with acute diarrhoea.6 The study revealed an association between axillary temperature and plasma zinc concentrations. As such, a reduction was seen in the mean plasma zinc concentration per degree of increased axillary temperature (0.59 μmol/L per ºC). Reduced plasma zinc levels were also associated with elevated levels of C-reactive protein, dysentery and decreased plasma albumin levels. The study also found that there were increased levels of plasma zinc in children who were dehydrated compared to those who were not